Insmed Incorporated(NASDAQ:INSM) 
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is...
Website: http://www.insmed.com
Founded: 1988
Full Time Employees: 435
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 70.43
H 72.50
L 67.80
C 69.18
V 3,120,022
10EMA 69.18
20EMA 69.18
60EMA 69.18
120EMA 69.18
250EMA 69.18